Leave Your Message
Good news | Aperbio was named a "specialized, sophisticated and innovative" small and medium-sized enterprise in the High-tech Zone in 2022

Company news

Good news | Aperbio was named a "specialized, sophisticated and innovative" small and medium-sized enterprise in the High-tech Zone in 2022

2024-04-26

In order to promote the high-quality development of small and medium-sized enterprises in the high-tech zone, further promote the transformation and upgrading of small and medium-sized enterprises in the high-tech zone, and implement the gradient cultivation plan of "specialized, refined, and new" small and medium-sized enterprises in the high-tech zone, Suzhou High-tech Zone (Huqiu District) Economic Development Committee organized the application and certification of "specialized, refined, and new" small and medium-sized enterprises in the district in 2022. After the review, Apbai Bio was awarded the title of "specialized, refined, and new" small and medium-sized enterprise in the high-tech zone in 2022.

Thanks to Suzhou High-tech Zone (Huqiu District) Economic Development Committee for its support to ApBio. ApBio focuses on the research and development of cutting-edge life science technologies and their application in personalized medicine. It is committed to the research and development, production, sales and service of medical diagnostic products, and strives to become a leading enterprise in the medical industry and work tirelessly for the Healthy China Dream!

Aperbio

Instrument development platform based on multiple fluorescence detection technology

————————————————————

Aperbio Technologies(Suzhou) co., Ltd. is located in Jiangsu Medical Device Technology Industrial Park. It has passed the national high-tech enterprise and has a 2,500-square-meter production plant. As a solution provider for clinical molecular testing, Apbai Biotech is committed to the research and development, production, sales and service of medical diagnostic products (diagnostic reagents, instruments). Based on the Naica CN digital PCR platform and its own patented detection technology, the company continues to develop genetic testing projects and kits for disease diagnosis and treatment using free DNA as detection materials. It is mainly used in dozens of clinical testing products such as disease-related molecular and cytogenetic tests, molecular diagnostic tests guided by targeted medication, etc., with simple operation, rapid results, simple analysis and high sensitivity.
At the same time, Cielo Dx real-time fluorescence PCR analyzer, as an instrument and equipment for Apbai Biotech's PCR product series solution, inherits Apbai Biotech's consistent excellent quality, which can not only provide you with highly sensitive and reliable results for testing, but also provide reliable performance guarantee for the clinical application of molecular diagnostic reagents.
Aperbio has a number of core technologies in detection instruments and reagents, and has obtained more than ten domestic and foreign patent authorizations and a number of software copyrights. The company has passed ISO9001, ISO13485 and other certifications and has a complete quality management system. After the company's digital PCR system obtained the medical device registration certificate in March 2021, the real-time fluorescence PCR analyzer was also approved for the medical device registration certificate.